Englander Institute for Precision Medicine

Mitochondrial control of inflammation.

TitleMitochondrial control of inflammation.
Publication TypeJournal Article
Year of Publication2023
AuthorsMarchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L
JournalNat Rev Immunol
Volume23
Issue3
Pagination159-173
Date Published2023 Mar
ISSN1474-1741
KeywordsAlarmins, Humans, Inflammation, Mitochondria, Neoplasms
Abstract

Numerous mitochondrial constituents and metabolic products can function as damage-associated molecular patterns (DAMPs) and promote inflammation when released into the cytosol or extracellular milieu. Several safeguards are normally in place to prevent mitochondria from eliciting detrimental inflammatory reactions, including the autophagic disposal of permeabilized mitochondria. However, when the homeostatic capacity of such systems is exceeded or when such systems are defective, inflammatory reactions elicited by mitochondria can become pathogenic and contribute to the aetiology of human disorders linked to autoreactivity. In addition, inefficient inflammatory pathways induced by mitochondrial DAMPs can be pathogenic as they enable the establishment or progression of infectious and neoplastic disorders. Here we discuss the molecular mechanisms through which mitochondria control inflammatory responses, the cellular pathways that are in place to control mitochondria-driven inflammation and the pathological consequences of dysregulated inflammatory reactions elicited by mitochondrial DAMPs.

DOI10.1038/s41577-022-00760-x
Alternate JournalNat Rev Immunol
PubMed ID35879417
PubMed Central IDPMC9310369
Grant ListU54 CA274291 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021